SCHEMBL32688231

SCHEMBL32688231

N#Cc1c(-c2cccc(N3CCCc4ccccc43)c2)cc(=O)[nH]c1SCc1nnn[nH]1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 10/20 0.36
▸ TSHR P16473 6/20 0.34
▸ MAPT P10636 6/20 0.34
▸ HPGD P15428 4/20 0.34
▸ TP53 P04637 2/20 0.34
▸ HSD11B1 P28845 5/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ KDM4E B2RXH2 3/20 0.33
▸ HTT P42858 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ USP2 O75604 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ ALOX15 P16050 2/20 0.32
▸ ADORA3 P0DMS8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32688274 0.90 BRD4 (0.38) ALDH1A1TSHRHPGDHSD11B1KMT2A
SCHEMBL32688472 0.84 GRK6 (0.36) ALDH1A1HPGDHSD11B1KMT2AKDM4E
SCHEMBL32688199 0.84 HSD11B1 (0.36) ALDH1A1TSHRMAPTHPGDHSD11B1
SCHEMBL32688310 0.84 GRK6 (0.37) ALDH1A1HPGDHSD11B1KMT2AKDM4E
SCHEMBL32688425 0.82 KISS1R (0.39) ALDH1A1
SCHEMBL32688262 0.81 GRK6 (0.37) HSD11B1ADORA3ADORA2AADORA2BADORA1
SCHEMBL32688163 0.81 KISS1R (0.39) TP53CYP3A4HTT
SCHEMBL32687986 0.80 KMT2A (0.39) ALDH1A1HPGDHSD11B1KMT2AKDM4E
SCHEMBL32688223 0.79 KISS1R (0.35) ALDH1A1TSHRMAPTHPGDHSD11B1
SCHEMBL32688048 0.77 BRD4 (0.38) ALDH1A1TSHRMAPTHPGDTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors ORSOBIO INC (US) 2026-03-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078105-A1 Novel Aminocarboxymuconate Semialdehyde Decarboxylase Inhibitors CPT1B, CBR1, MUSK ALDH1A1 290/4885TSHR 983/4885MAPT 4018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback